Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
US Weekly on MSN7d
What Celebrities and Doctors Have Said About Ketamine Use: Chrissy Teigen, Matthew Perry, MoreCelebrities like Chrissy Teigen and Matthew Perry have been open about using ketamine for their mental health – here's what ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
The following is a summary of “Intranasal racemic ketamine maintenance therapy for patients with treatment-resistant ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Get your itchy fingers ready — Samsung’s Galaxy Unpacked event is today at 1pm Eastern, which means the long-awaited ...
Lorna Staines discusses a longitudinal population-based study examining the risks of using psychedelics in a naturalistic ...
The connection between M. morganii, inflammation, and depression aligns with earlier research. IL-6 has been repeatedly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback